Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04498130 · ClinicalTrials.gov registry record · NA

Feasibility of a Novel, Theory Based Physical Activity Intervention Among Adult Cancer Survivors

A NA study, sponsored by University of Illinois at Urbana-Champaign.

Completed
Registry status
NA
Development phase
29
Enrollment target

NCT04498130 is a NA study that has completed, run by University of Illinois at Urbana-Champaign. The registered enrollment target is 29 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04498130, a NA study, has completed, sponsored by University of Illinois at Urbana-Champaign.

COMPLETED
Registry status
NA
Development phase
29 participants
Enrollment target

Study Summary

As the number of cancer survivors grows and expected survival time increases, the health behaviors of this population are gaining significant attention from the research and public health community. Adoption or maintenance of healthy lifestyles after cancer has the potential to reduce both cancer- and non-cancer-related morbidity and mortality. Exercise adoption and maintenance remains a significant challenge for adults, especially clinical populations such as cancer survivors who may struggle with comorbidities, symptoms and side-effects of the disease or medications, and overall compromised health and functioning. A number of site-based exercise interventions have been conducted to promote physical activity, often using a theoretical basis to design and execute the intervention. Although these programs are successful in exposing cancer survivors to regular physical activity, they often struggle with exercise maintenance after the conclusion of the structured site-based group exercise sessions. The goal of the proposed project is to enhance physical activity engagement among adult cancer survivors by designing a home-based program using the socio-ecological framework and employing constructs from social cognitive theory to guide participants through the project.

Interventions

  • BEHAVIORAL 12-Week Home Exercise Group
  • BEHAVIORAL Education Comparison Group

Trial Details

FieldValue
Enrollment Target 29 participants
Start Date 2021-10-02
Est. Completion 2022-12-31
Phase NA

What the Registry Record Tells You About NCT04498130

The ClinicalTrials.gov registry entry for NCT04498130 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 29 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Illinois at Urbana-Champaign, which has 129 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which 12-Week Home Exercise Group is the first listed.

NCT04498130 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04498130 about?

NCT04498130 is a clinical study titled "Feasibility of a Novel, Theory Based Physical Activity Intervention Among Adult Cancer Survivors". As the number of cancer survivors grows and expected survival time increases, the health behaviors of this population are gaining significant attention from the research and public health community. Adoption or maintenance of healthy lifestyles after cancer has the potential to reduce both cancer- a...

What is the current status of trial NCT04498130?

This trial is currently completed. It is a NA study. The enrollment target is 29 participants. The study started on 2021-10-02. Estimated completion is 2022-12-31.

What interventions are being tested in trial NCT04498130?

The interventions under investigation include: 12-Week Home Exercise Group (BEHAVIORAL), Education Comparison Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT04498130?

This trial is sponsored by University of Illinois at Urbana-Champaign, which has 129 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.